New York Oncology Hematology P.C ( Site 9000) — Albany, New York

Public research footprint of New York Oncology Hematology P.C ( Site 9000), compiled from the ClinicalTrials.gov public registry.

104

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Renal Cell · Non-small Cell Lung Cancer · Breast Cancer · Metastatic Renal Cell Cancer

Recently updated registry entries

NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)
NCT06717347 — A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… (Recruiting)
NCT03435796 — Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at New York Oncology Hematology P.C ( Site 9000)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.